Chelation

EDTA (edetic acid) is a chemical compound that binding metal metal ions. EDTA salts facilitate the removal of metals and minerals from the body. Chelating therapy was first used in the 1950s to treat heavy metal poisoning. The EDTA compound is administered intravenously in the form of a drip (less often intramuscularly or orally). We do not recommend the use of chelation therapy for the treatment of atherosclerosis, as there is insufficient evidence confirming its effectiveness.

Burning is the most common side effect of EDTA salt intravenous administration. Other sides effect are like nausea, vomiting, headache and fever are less common. Rarely EDATA administration may cause a drop in blood pressure, hypocalcaemia (calcium deficiency), permanent kidney damage and bone marrow suppression. Chelating drip should only be administered by qualified medical personnel on the recommendation of a doctor.